Reliability and validity of the turkish translation of pedsql™ multidimensional Fatigue scale in Duchenne Muscular Dystrophy

References

1. ↵
   1. Yiu EM,
   2. Kornberg AJ

   (2008) Duchenne muscular dystrophy. Neurol India 56, 236–247.
2. ↵
   1. Fernandes LA,
   2. Caromano FA,
   3. Hukuda ME,
   4. Escorcio R,
   5. Carvalho EV

   (2010) Elaboration and reliability of functional evaluation on going up and downstairs scale for Duchenne Muscular Dystrophy. Rev Bras Fisioter 14, 518–526.
3. ↵
   1. Bushby K,
   2. Finkel R,
   3. Birnkrant D,
   4. Case L,
   5. Clemens P,
   6. Cripe L,
   7. et al.

   (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9, 77–93.
4. ↵
   1. Hoffman E,
   2. Brown R,
   3. Kunkel L

   (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919–928.
5. ↵
   1. Féasson L,
   2. Camdessanché JP,
   3. El Mandhi L,
   4. Calmels P,
   5. Millet GY

   (2006) Fatigue and neuromuscular diseases. Ann Readapt Med Phys 49, 289–300.
6. ↵
   1. Goemans N,
   2. van den Hauwe M,
   3. Wilson R,
   4. van Impe A,
   5. Klingels K,
   6. Buyse G

   (2013) Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids. Neuromuscul Disord 23, 618–623.
7. ↵
   1. Dubowitz V

   , ed Muscle disorders in childhood (W.B. Saunders, Edinburgh (UK)), 2004.
8. ↵
   1. Romani A

   (2008) The treatment of fatigue. J Neurol Sci 29, 247–249.
9. ↵
   1. Kalkman J,
   2. Schillings M,
   3. Zwarts M,
   4. van Engelen B,
   5. Bleijenberg G

   (2007) The development of a model of fatigue in neuromuscular disorders: a longitudinal study. J Psychosom Res 62, 571–579.
10. ↵
    1. Brooke M,
    2. Griggs R,
    3. Mendell J,
    4. Fenichel G,
    5. Shumate J,
    6. Pellegrino R

    (1981) Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve 4, 186–197.
11. ↵
    1. Varni JW,
    2. Burwinkle TM,
    3. Szer IS

    (2004) The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity. J Rheumatol 31, 2494–2500.
12. ↵
    1. Scale MF,
    2. Varni JW,
    3. Burwinkle TM,
    4. Katz ER,
    5. Meeske K,
    6. et al.

    (2002) The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer 94, 2090–2106.
13. ↵
    1. Varni JW,
    2. Burwinkle TM,
    3. Katz ER,
    4. Meeske K,
    5. Dickinson P

    (2002) The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer 94, 2090–2106.
14. ↵
    1. Sienko Thomas S,
    2. Buckon CE,
    3. Nicorici A,
    4. Bagley A,
    5. McDonald CM,
    6. Sussman MD

    (2010) Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function. J Child Neurol 25, 1103–1109.
15. ↵
    1. Du H,
    2. Newton P,
    3. Salamonson Y,
    4. Carrieri-Kohlman V,
    5. Davidson P

    (2009) A Review of the Six-Minute Walk Test: Its Implication as a Self-Administered Assessment Tool. Eur J Cardiovasc Nurs 8, 2–8.
16. ↵
    1. Mazzone E,
    2. Martinelli D,
    3. Berardinelli A,
    4. Messina S,
    5. D’Amico A,
    6. Vasco G,
    7. et al.

    (2010) North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul Disord 20, 712–716.
17. ↵
    1. Mazzone E,
    2. Messina S,
    3. Vasco G,
    4. Main M,
    5. Eagle M,
    6. D’Amico A,
    7. et al.

    (2009) Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord 19, 458–61.
18. ↵
    1. Davis S,
    2. Hynan L,
    3. Limbers C,
    4. Andersen C,
    5. Greene M,
    6. Varni J,
    7. et al.

    (2010) The PedsQL™ in Pediatric Patients with Duchenne Muscular Dystrophy: Feasibility, Reliability, and Validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales. J Clin Neuromuscul Dis 11, 97–109.
19. ↵
    1. McHorney C,
    2. Ware J,
    3. Rachel Lu J,
    4. Sherbourne C

    (1994) The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups. Med Care 32, 40–66.
20. ↵
    1. Cronbach L

    (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16, 297–334.
21. ↵
    1. Lachenbruch P,
    2. Cohen J

    (1989) Statistical Power Analysis for the Behavioral Sciences (2nd ed.). J Am Stat Assoc 84, 1096.
22. ↵
    1. Bentler P,
    2. Bonett D

    (1980) Significance tests and goodness of fit in the analysis of covariance structures. Psychol Bull 88, 588–606.
23. ↵
    1. Hu J,
    2. Jiang L,
    3. Hong S,
    4. Cheng L,
    5. Kong M,
    6. Ye Y

    (2013) Reliability and validity of the Chinese version of the pediatric quality of life inventoryTM (PedsQLTM) 3.0 neuromuscular module in children with Duchenne muscular dystrophy. Health Qual Life Outcomes 11, 47.
24. ↵
    1. Kobayashi K,
    2. Okano Y,
    3. Hohashi N

    (2011) Reliability and validity of the PedsQL™ Multidimensional Fatigue Scale in Japan. Qual Life Res 20, 1091–1102.
25. ↵
    1. Ye Q,
    2. Liu K,
    3. Wang J,
    4. Bu X,
    5. Zhao L

    (2016) Reliability and validity of the Chinese version of the PedsQL Multidimensional Fatigue Scale in children with acute leukemia. IJNSS 3, 146–152.
26. ↵
    1. Varni JW,
    2. Limbers CA,
    3. Bryant WP,
    4. Wilson DP

    (2009) The PedsQL Multidimensional Fatigue Scale in type 1 diabetes: feasibility, reliability, and validity. Pediatr Diabetes 10, 321–328.
27. ↵
    1. Achenbach T,
    2. McConaughy S,
    3. Howell C

    (1987) Child/adolescent behavioral and emotional problems: Implications of cross-informant correlations for situational specificity. Psychol Bull 101, 213–232.
28. ↵
    1. Sneeuw KC,
    2. Sprangers MA,
    3. Aaronson NK

    (2002) The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J Clin Epidemiol 55, 1130–1143.